These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 36127853

  • 21. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis.
    Heiranizadeh N, Rafiei Shahamabadi M, Dehghan HR, Jafari-Nedooshan J, Kargar S, Zare M, Amooei A, Shiryazdi SM, Broomand MA, Moravej MT, Sadri Z.
    Asian Pac J Cancer Prev; 2022 Aug 01; 23(8):2561-2571. PubMed ID: 36037108
    [Abstract] [Full Text] [Related]

  • 22. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
    Majid S, Rydén L, Manjer J.
    BMC Cancer; 2019 Jun 25; 19(1):626. PubMed ID: 31238899
    [Abstract] [Full Text] [Related]

  • 23. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
    Lee SK, Lee KW, Kim S, Choi MY, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ.
    Oncology; 2012 Jun 25; 83(1):31-7. PubMed ID: 22722529
    [Abstract] [Full Text] [Related]

  • 24. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C, Walters D, de Silva P, Taylor C, Spillane A, Kollias J, Pyke C, Campbell I, Maddern G.
    Breast; 2013 Dec 25; 22(6):1215-9. PubMed ID: 24157405
    [Abstract] [Full Text] [Related]

  • 25. The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study.
    Poodt IGM, Rots ML, Vugts G, van Dalen T, Kuijer A, Vriens BEPJ, Nieuwenhuijzen GAP, Schipper RJ.
    Eur J Surg Oncol; 2018 Aug 25; 44(8):1151-1156. PubMed ID: 29580733
    [Abstract] [Full Text] [Related]

  • 26. Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.
    Cyr A, Gao F, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.
    Ann Surg Oncol; 2012 Oct 25; 19(10):3185-91. PubMed ID: 22890591
    [Abstract] [Full Text] [Related]

  • 27. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
    Delpech Y, Bricou A, Lousquy R, Hudry D, Jankowski C, Willecocq C, Thoury A, Loustalot C, Coutant C, Barranger E.
    Ann Surg Oncol; 2013 Aug 25; 20(8):2556-61. PubMed ID: 23456432
    [Abstract] [Full Text] [Related]

  • 28. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Tsao MW, Cornacchi SD, Hodgson N, Simunovic M, Thabane L, Cheng J, O'Brien MA, Strang B, Mukherjee SD, Lovrics PJ.
    Ann Surg Oncol; 2016 Oct 25; 23(10):3354-64. PubMed ID: 27342830
    [Abstract] [Full Text] [Related]

  • 29. Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Sanders SB, Hoskin TL, Stafford AP, Boughey JC.
    Ann Surg Oncol; 2022 Nov 25; 29(12):7769-7778. PubMed ID: 35834142
    [Abstract] [Full Text] [Related]

  • 30. Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.
    Davis J, Boughey JC, Hoskin TL, Day CN, Cheville JC, Piltin MA, Hieken TJ.
    Clin Breast Cancer; 2021 Oct 25; 21(5):458-465. PubMed ID: 33839043
    [Abstract] [Full Text] [Related]

  • 31. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
    Aslani N, Swanson T, Kennecke H, Woods R, Davis N.
    Can J Surg; 2011 Aug 25; 54(4):237-42. PubMed ID: 21651836
    [Abstract] [Full Text] [Related]

  • 32. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF.
    Dan Med J; 2017 Oct 25; 64(10):. PubMed ID: 28975889
    [Abstract] [Full Text] [Related]

  • 33. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
    Gray RJ, Pockaj BA, Conley CR.
    Ann Surg Oncol; 2004 Dec 25; 11(12):1056-60. PubMed ID: 15545503
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
    Huang TW, Kuo KN, Chen KH, Chen C, Hou WH, Lee WH, Chao TY, Tsai JT, Su CM, Huang MT, Tam KW.
    Int J Surg; 2016 Oct 25; 34():73-80. PubMed ID: 27562691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.